New Zealand markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.70+0.06 (+0.90%)
At close: 04:00PM EDT
6.68 -0.02 (-0.30%)
After hours: 06:38PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.64
Bid6.65 x 2200
Ask6.80 x 1000
Day's range6.62 - 6.88
52-week range3.28 - 14.42
Avg. volume813,330
Market cap445.895M
Beta (5Y monthly)0.27
PE ratio (TTM)N/A
EPS (TTM)-6.24
Earnings date31 Oct 2022 - 04 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est10.70
  • GlobeNewswire

    Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    ANN ARBOR, Mich., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that, on August 2, 2022, the Compensation Committee of Esperion’s Board of Directors granted 13 new employees 66,000 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan. The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fid

  • Zacks

    Esperion (ESPR) Q2 Earnings and Revenues Miss Estimates

    Esperion Therapeutics (ESPR) reports dismal second-quarter results, missing estimates for earnings and sales. However, shares rose on the back of ESPR's progress with its cardiovascular outcome study.

  • Motley Fool

    Esperion Therapeutics (ESPR) Q2 2022 Earnings Call Transcript

    Image source: The Motley Fool. Esperion Therapeutics (NASDAQ: ESPR)Q2 2022 Earnings CallAug 02, 2022, 8:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorLadies and gentlemen, thank you for standing by.